Semaglutide, a glucagon-like peptide-1 receptor agonist, may be associated with increased risk of a rare eye condition, results from a large-scale retrospective study have suggested
Rustelle Janse van Vuuren 1,2 , Pier-Olivier Martel 1,2 , and Patrick Narbonne 1,2 1 Dpartement de Biologie Mdicale, Universit du Qubec Trois-Rivires, Trois-Rivires, Qubec, Canada 2 Groupe de Recherche en Signalisation Cellulaire, Universit du Qubec Trois-Rivires, Trois-Rivires, Qubec, Canada Correspondence to: Patrick Narbonne ([email protected]) Anonymous Anonymous Database Reference ID: WBPaper00068915 2025 by the authors
a study of il-1 and ido gene polymorphisms in patients with schizophrenia
doi:10.1093/ehjcvp/pvad001